summary
Introduced
02/16/2023
02/16/2023
In Committee
03/11/2024
03/11/2024
Crossed Over
Passed
Dead
12/31/2024
12/31/2024
Introduced Session
193rd General Court
Bill Summary
For legislation relative to the care and treatment of patients with mitochondrial disease. Financial Services.
AI Summary
This bill requires the Massachusetts Group Insurance Commission and various health insurance providers in the state to provide coverage for the treatment of mitochondrial disease, which includes the use of specific vitamin and nutritional supplements such as CoEnzyme Q10, Vitamin E, Vitamin C, Vitamin B1, Vitamin B2, Vitamin K1, and L-Carnitine. The bill aims to ensure that active and retired Commonwealth employees, as well as individuals with private insurance policies, have access to the necessary treatments for this genetic disorder that affects the mitochondria, which are responsible for producing energy in cells.
Committee Categories
Business and Industry, Health and Social Services
Sponsors (1)
Last Action
Accompanied a study order, see H4634 (on 05/09/2024)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://malegislature.gov/Bills/193/S660 |
| BillText | https://malegislature.gov/Bills/193/S660.pdf |
Loading...